El Salvador’s $1.6B Bitcoin City Investment Unveiledby John Darbie 14.08.2024El Salvador partners with Yilport Holdings to build Bitcoin City, boosting trade and modernizing ports with a $1.6B investment.
Kezar Shifts Focus From Tumor Drug to Autoimmune Therapyby Lilu Anderson 14.08.2024Kezar halts tumor drug trials, pivots to autoimmune hepatitis focus with promising zetomipzomib.
Nasdaq Gains, Dow Slips Amid Inflation Concernsby Mark Eisenberg 14.08.2024Nasdaq edges up while Dow declines as investors await key signals on inflation and the economy after a volatile trading ...
BP Tech May Drill on Mars After NASA Dealby Lilu Anderson 14.08.2024BP's tech could explore Mars or Moon post NASA deal, sharing expertise from hostile environments.
PDS Biotech’s Q2 2024 Update: Clinical Progressby Lilu Anderson 13.08.2024PDS Biotech aligns with FDA for Phase 3 trial, reports Q2 2024 financials with reduced net loss and expenses.
MITRE Enhances ICS ATT&CK Evaluationsby Lilu Anderson 13.08.2024MITRE seeks contributions to enrich ICS ATT&CK emulation by evaluating insider threat behaviors in industrial control systems.
AI Predicted to Boost Returns in Biotech Stocksby Lilu Anderson 13.08.2024AI integration in biotech could reduce R&D costs, enhance efficiency, and increase returns for investors.
Legend Biotech’s Q2 2024 Earnings: Growth & Strategyby Lilu Anderson 12.08.2024Legend Biotech reports significant revenue growth in Q2 2024, with strategic advancements in CAR-T therapies.
Britain’s CEOs Receive Record Pay in 2023by Mark Eisenberg 12.08.2024Research shows UK's top executives earn record pay as workers demand higher wages amid economic challenges.
InspireMD Eyes US Launch Amid Revenue Growthby Mark Eisenberg 11.08.2024InspireMD reports revenue growth in Q2 2024 and plans to launch CGuard Prime in the US by 2025, despite current ...